These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 21187590

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of dosing frequency of teriparatide (PTH 1-34) on bone formation in rats: comparison of bone metabolism marker levels.
    Watanabe A, Tsurui K, Yoneyama S, Iwata H, Anzai T, Jerome C, Nakae D.
    J Toxicol Sci; 2018; 43(7):435-442. PubMed ID: 29973475
    [Abstract] [Full Text] [Related]

  • 24. Treatment of osteoporosis with Teriparatide rhPTH(1-34).
    San Martin J.
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):406. PubMed ID: 15758281
    [No Abstract] [Full Text] [Related]

  • 25. [hPTH(1-34) injection].
    Uzawa T, Yamauchi H.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():548-54. PubMed ID: 15035188
    [No Abstract] [Full Text] [Related]

  • 26. Effect of Time of Administration of Teriparatide on Bone Mineral Density in Glucocorticoid-Induced Osteoporosis.
    Mastaglia SR.
    J Clin Densitom; 2017 Feb; 20(4):513-515. PubMed ID: 28579148
    [Abstract] [Full Text] [Related]

  • 27. Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment.
    Miki T, Nakatsuka K, Naka H, Masaki H, Imanishi Y, Ito M, Inaba M, Morii H, Nishizawa Y.
    J Bone Miner Metab; 2004 Feb; 22(6):569-76. PubMed ID: 15490267
    [Abstract] [Full Text] [Related]

  • 28. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure.
    Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF.
    J Bone Miner Res; 2003 Nov; 18(11):1932-41. PubMed ID: 14606504
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide.
    Takeuchi Y, Kuroda T, Sugimoto T, Shiraki M, Nakamura T.
    Calcif Tissue Int; 2016 Feb; 98(2):186-92. PubMed ID: 26478225
    [Abstract] [Full Text] [Related]

  • 31. Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study.
    Sugimoto T, Shiraki M, Fukunaga M, Kishimoto H, Hagino H, Sone T, Nakano T, Ito M, Yoshikawa H, Minamida T, Tsuruya Y, Nakamura T.
    Osteoporos Int; 2019 Nov; 30(11):2321-2331. PubMed ID: 31392401
    [Abstract] [Full Text] [Related]

  • 32. [The Importance of teriparatide in the treatment of osteoporosis].
    Yamauchi M.
    Clin Calcium; 2016 Jun; 26(6):905-13. PubMed ID: 27230847
    [Abstract] [Full Text] [Related]

  • 33. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
    Gallagher JC, Rosen CJ, Chen P, Misurski DA, Marcus R.
    Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
    [Abstract] [Full Text] [Related]

  • 34. A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis.
    Sone T, Fukunaga M, Ono S, Nishiyama T.
    Miner Electrolyte Metab; 1995 Dec; 21(1-3):232-5. PubMed ID: 7565456
    [Abstract] [Full Text] [Related]

  • 35. Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.
    Muscoso E, Puglisi N, Mamazza C, Lo Giudice F, Testai M, Abbate S, Santangelo A, Panebianco P, Maugeri D.
    Eur Rev Med Pharmacol Sci; 2004 Dec; 8(2):97-102. PubMed ID: 15267123
    [Abstract] [Full Text] [Related]

  • 36. Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women.
    Uusi-Rasi K, Semanick LM, Zanchetta JR, Bogado CE, Eriksen EF, Sato M, Beck TJ.
    Bone; 2005 Jun; 36(6):948-58. PubMed ID: 15878318
    [Abstract] [Full Text] [Related]

  • 37. Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis.
    Sugiura T, Kashii M, Matsuo Y, Morimoto T, Honda H, Kaito T, Iwasaki M, Yoshikawa H.
    Spine J; 2015 Feb 01; 15(2):298-306. PubMed ID: 25110274
    [Abstract] [Full Text] [Related]

  • 38. Effects of differences in dose and frequency of teriparatide on bone structure in Proximal Femur. - Analysis by DXA-based 3D-modeling (3D-SHAPER Software) -TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineraL density increase and BONE structure).
    Takada J, Okimoto N, Tsukamoto M, Akatsuka T, Takebayashi T, Iba K, Ikeda S.
    Arch Osteoporos; 2024 Jul 02; 19(1):55. PubMed ID: 38954145
    [Abstract] [Full Text] [Related]

  • 39. New insights into the role of teriparatide.
    Resmini G, Iolascon G.
    Aging Clin Exp Res; 2011 Apr 02; 23(2 Suppl):30-2. PubMed ID: 21970914
    [Abstract] [Full Text] [Related]

  • 40. Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis.
    Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL.
    J Bone Miner Res; 2003 Mar 02; 18(3):539-43. PubMed ID: 12619939
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.